VWF and COVID-19: In this study, we evaluated NET markers and vWF levels in the plasma of COVID-19 patients, with or without a thrombotic event during hospitalization, to identify if these biomarkers are associated with an increased risk of thrombosis in patients with COVID-19 and can predict thrombotic events in COVID-19 patients.